1-11 of 11
Wen Juan Yu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax Combined with Hag Regimen in Newly Diagnosed ETP-ALL: Interim Analysis of a Prospective, Multicenter, Phase 2 Trial

Shanshan Suo, Wen-Juan Yu, Ying Lu, Jiejing Qian, Liping Mao, Jin Wang, Lijing Shen, Bingzong Li, Huafeng Wang, Wenyuan MAI, Wanzhuo Xie, Xiaomin Wang, Dan Zhao, Yuanfang Liu, Chuan He, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 2869.
https://doi.org/10.1182/blood-2023-191190
Published: 2023
Journal Articles

Chidamide As Maintenance in Peripheral T-Cell Lymphoma for Patients in Response after Induction Therapy: A Single Center Retrospective Study

Yanan Zhu, Juying Wei, Chunmei Yang, Wanzhuo Xie, Yanhong Tong, Wen-Juan Yu, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6183.
https://doi.org/10.1182/blood-2023-180495
Published: 2023
Journal Articles

Combination of Olverembatinib and VP Regimen As First-Line Therapy for Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Gaixiang Xu, Yinjun Lou, Huafeng Wang, Wen-Juan Yu, Liping Mao, Jian Huang, Chenying Li, Shanshan Suo, Hongyan Tong, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 4205.
https://doi.org/10.1182/blood-2023-187130
Published: 2023
Journal Articles

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of the EB Subtype of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Gaixiang Xu, Wei Wang, Shuanghong Zhu, Kongfei Li, Xinping Zhou, Liya Ma, Li Ye, Chen Mei, Lu Wang, Lingxu Jiang, Haitao Meng, Wen-Juan Yu, Jie Jin, Hongyan Tong, Jian Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6481.
https://doi.org/10.1182/blood-2023-184789
Published: 2023
Journal Articles

The ZR2-Minichop Study：Zanubrutinib, Lenalidomide, Rituximab, Cyclophosphamide, Vincristine, Epirubicin and Prednisone in Elderly Patients with Previously Untreated Diffuse Large B-Cell Lymphoma

Jianai Sun, Yi Xu, Yuanfei Shi, Jinghan Wang, Xueying Li, Xiaolong Zheng, Wen-Juan Yu, Hongyan Tong, Jie Jin, Wanzhuo Xie
Journal: Blood
Blood (2023) 142 (Supplement 1): 6224.
https://doi.org/10.1182/blood-2023-186591
Published: 2023
Journal Articles

Risk Factors for Severe Infection and Unfavorable Outcomes in Hematologic Malignancy Patients with COVID-19 Inflection during the Omicron Era: A Chinese Single-Center Retrospective Study

Li Ye, Ye Yang, Xuewu Zhang, Lu Wang, Li Zhu, Xia Li, Yile Zhou, Xiaolong Zheng, Xinping Zhou, Yanling Ren, Liya Ma, Gaixiang Xu, Chunmei Yang, Huafeng Wang, De Zhou, Min Yang, Xingnong Ye, Juying Wei, Wen-Juan Yu, Jiejing Qian, Yinjun Lou, Wanzhuo Xie, Jian Huang, Haitao Meng, Jie Jin, Hongyan Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 5384.
https://doi.org/10.1182/blood-2023-184470
Published: 2023
Journal Articles

Efficacy and Safety of Clifutinib, a Novel, Highly Selective, Oral FLT3 Inhibitor, in Patients with FLT3-Mutated Relapsed or Refractory Acute Myeloid Leukemia：Updated Results from a Phase I Study

Jie Jin, Huafeng Wang, Wen-Juan Yu, Zheng Ge, Xudong Wei, Yuhua Li, Zhongxing Jiang, Yiqing Li, Xin Du, Linhua Yang, Lie Lin, Jishi Wang, Yazhou Yao, Xiaoping Hu, Jianping Lan, Xiuzhi Deng, Tong Chen, Xianqi Feng, Dengju Li, Ming Hou, Rong Fu, Siyong Huang, Jingbo Wang, Xin Du, Hui Yang, Haiping Yang, Yingzhi Jiang, Zhijie Wang, Deng Li, Bing Liu, Ning Kang, Yulei Zhuang, Yingjun Zhang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4281.
https://doi.org/10.1182/blood-2023-188961
Published: 2023
Journal Articles

C-CAR039, a Novel Anti-CD20/CD19 Bi-Specific CAR T-Cell Therapy Shows Deep and Durable Clinical Benefits in Patients with Relapsed or Refractory (r/r) B-Cell Non-Hodgkin Lymphoma (B-NHL) in Long Term Follow up

Ping Li, Wen-Juan Yu, Lili Zhou, Min Yang, Shiguang Ye, Judy Zhu, Jiaqi Huang, Yan Zhang, Lanfang Li, Jing Zhao, Kevin Zhu, Jing Li, Chengxiao Zheng, Liping Lan, Hui Wan, Yihong Yao, Huilai Zhang, Daobin Zhou, Jie Jin, Aibin Liang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1025.
https://doi.org/10.1182/blood-2023-182817
Published: 2023
Journal Articles

How Induction Cycles before Remission Influence Long-Term Survival in Acute Myeloid Leukemia

Feng Zhu, Nianci Chen, Yile Zhou, Yi Zhang, Jian Huang, Wanzhuo Xie, Haitao Meng, Wen-Juan Yu, Liping Mao, Wenyuan MAI, Chunmei Yang, Juying Wei, Yinjun Lou, Min Yang, Jiejing Qian, Gaixiang Xu, De Zhou, Liya Ma, Xingnong Ye, Yanling Ren, Hongyan Tong, Huafeng Wang, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6001.
https://doi.org/10.1182/blood-2023-186048
Published: 2023
Journal Articles

Comparison of Subcutaneous Injection Versus Intravenous Infusion of Cytarabine for Induction Therapy in Young Adult Acute Myeloid Leukemia: Results of a Prospective, Multicenter, Noninferiority, Randomized Trial

Huafeng Wang, MD, LU LIU, MD, Jianfeng Zhou, MD PhD, Jianyong Li, MD PhD, Ying Lu, MD, Jianping Shen, MD, Chunyan Ji, MD, Tong Chen, MD PhD, Kang Yu, MD, Hanyun Ren, MD, Yan Li, MD, Dengju Li, MD, Ying Chen, MD, Shaolei Zang, MD, Bin Liang, MD, Sijing Kang, MD, Jinghan Wang, MDPhD, Wei Cheng, PhD, Haitao Meng, MD PhD, Wen-Juan Yu, Yanhong Tong, Honghu Zhu, MD, Jie Jin, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4.
https://doi.org/10.1182/blood-2020-143426
Published: 2020
Journal Articles

Impact of Chemotherapy Delay on Overall Survival for AML with I DH1/2 Mutations: A Study in Adult Chinese Patients

Jing Han Wang, PhDMD, Qi Guo, Zhi Xin Ma, Qiu Ling Ma, Meng Xia Yu, Xiu Feng Yin, Sha Sha Lu, Qiong Hong Xie, Yue Hong Jiang, Dan Shen, li Ya Ma, Hui Shi, Wen Juan Yu, Ye Jiang Lou, Ying Li, Min Yang, Gai Xiang Xu, Li Ping Mao, Jian Hu Li, Fan Ping Wang, Dong Mei Wang, Ju Ying Wei, Hong Yan Tong, Jian Huang, Jie Jin, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4905.
https://doi.org/10.1182/blood.V126.23.4905.4905
Published: 2015